{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,5]],"date-time":"2026-10-05T07:31:45Z","timestamp":1791185505496,"version":"4.1.0"},"reference-count":26,"publisher":"Elsevier BV","issue":"12","license":[{"start":{"date-parts":[[2009,12,1]],"date-time":"2009-12-01T00:00:00Z","timestamp":1259625600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2009,12,1]],"date-time":"2009-12-01T00:00:00Z","timestamp":1259625600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.fr","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Annales de Dermatologie et de V\u00e9n\u00e9r\u00e9ologie"],"published-print":{"date-parts":[[2009,12]]},"DOI":"10.1016\/j.annder.2009.09.010","type":"journal-article","created":{"date-parts":[[2009,10,24]],"date-time":"2009-10-24T04:33:11Z","timestamp":1256358791000},"page":"894-897","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":17,"title":["K\u00e9ratoacanthomes multiples \u00e9ruptifs induits par le soraf\u00e9nib"],"prefix":"10.1016","volume":"136","author":[{"given":"H.","family":"Jantzem","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"D.","family":"Dupre-Goetghebeur","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"P.","family":"Spindler","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"J.","family":"Merrer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.annder.2009.09.010_bib1","doi-asserted-by":"crossref","first-page":"1875","DOI":"10.2353\/ajpath.2006.050711","article-title":"Inhibition of tumor endothelial ERK activation, angiogenesis, and tumor growth by sorafenib (BAY43-9006)","volume":"169","author":"Murphy","year":"2006","journal-title":"Am J Pathol"},{"key":"10.1016\/j.annder.2009.09.010_bib2","doi-asserted-by":"crossref","first-page":"835","DOI":"10.1038\/nrd2130","article-title":"Discovery and development of sorafenib: a multikinase inhibitor for treating cancer","volume":"5","author":"Wilhelm","year":"2006","journal-title":"Nat Rev Drug Discov"},{"key":"10.1016\/j.annder.2009.09.010_bib3","doi-asserted-by":"crossref","first-page":"171","DOI":"10.1016\/j.jaad.2006.10.032","article-title":"Keratoacanthomas associated with sorafenib therapy","volume":"56","author":"Kong","year":"2007","journal-title":"J Am Acad Dermatol"},{"key":"10.1016\/j.annder.2009.09.010_bib4","doi-asserted-by":"crossref","first-page":"491","DOI":"10.1016\/S1470-2045(05)70243-6","article-title":"Cutaneous side-effects of kinase inhibitors and blocking antibodies","volume":"6","author":"Robert","year":"2005","journal-title":"Lancet Oncol"},{"key":"10.1016\/j.annder.2009.09.010_bib5","first-page":"S260","article-title":"Effets secondaires cutan\u00e9s des mol\u00e9cules anti-angiog\u00e9niques","volume":"94","author":"Robert","year":"2007","journal-title":"Bull Cancer"},{"key":"10.1016\/j.annder.2009.09.010_bib6","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1016\/S0151-9638(08)70093-0","article-title":"Effets secondaires cutan\u00e9s des nouvelles mol\u00e9cules anticanc\u00e9reuses\u00a0: focus sur les mol\u00e9cules ciblant les r\u00e9cepteurs tyrosine kinase et le r\u00e9cepteur \u00e0 l\u2019EGF","volume":"1","author":"Deslandres","year":"2008","journal-title":"Ann Dermatol Venereol"},{"key":"10.1016\/j.annder.2009.09.010_bib7","doi-asserted-by":"crossref","first-page":"148","DOI":"10.1016\/j.annder.2007.12.006","article-title":"Effets secondaires cutan\u00e9s du soraf\u00e9nib et du sunitinib","volume":"135","author":"Autier","year":"2008","journal-title":"Ann Dermatol Venereol"},{"key":"10.1016\/j.annder.2009.09.010_bib8","doi-asserted-by":"crossref","first-page":"545","DOI":"10.1016\/j.jaad.2008.01.001","article-title":"Chemotherapeutic agents and the skin: An update","volume":"58","author":"Heidary","year":"2008","journal-title":"J Am Acad Dermatol"},{"key":"10.1016\/j.annder.2009.09.010_bib9","first-page":"111","article-title":"Imputation des effets inattendus ou toxiques des m\u00e9dicaments. Actualisation de la m\u00e9thode utilis\u00e9e en France","volume":"40","author":"B\u00e9gaud","year":"1985","journal-title":"Therapie"},{"key":"10.1016\/j.annder.2009.09.010_bib10","doi-asserted-by":"crossref","first-page":"541","DOI":"10.1016\/j.annder.2008.03.001","article-title":"Vous avez dit k\u00e9ratoacanthome\u00a0? Dites plut\u00f4t \u00ab\u00a0carcinome spinocellulaire \u00e0 type de k\u00e9ratoacanthome\u00a0\u00bb","volume":"135","author":"Cribier","year":"2008","journal-title":"Ann Dermatol Venereol"},{"key":"10.1016\/j.annder.2009.09.010_bib11","first-page":"326","article-title":"Keratoacanthomas: a clinicopathologic enigma","volume":"30","author":"Schwartz","year":"2004","journal-title":"Derm Surg"},{"key":"10.1016\/j.annder.2009.09.010_bib12","doi-asserted-by":"crossref","first-page":"36","DOI":"10.5070\/D36B8870C5","article-title":"Generalized eruptive keratoacanthomas","volume":"9","author":"Chu","year":"2003","journal-title":"Dermatol Online J"},{"key":"10.1016\/j.annder.2009.09.010_bib13","doi-asserted-by":"crossref","first-page":"19","DOI":"10.5070\/D30MN783R4","article-title":"Multiple eruptive keratoacanthomas, de novo","volume":"10","author":"Wee","year":"2004","journal-title":"Dermatol Online J"},{"key":"10.1016\/j.annder.2009.09.010_bib14","doi-asserted-by":"crossref","first-page":"478","DOI":"10.1016\/S0190-9622(97)70150-6","article-title":"Eruptive keratoacanthomas associated with immunosuppressive therapy in a patient with systemic lupus erythematosus","volume":"37","author":"Dessoukey","year":"1997","journal-title":"J Am Acad Dermatol"},{"key":"10.1016\/j.annder.2009.09.010_bib15","doi-asserted-by":"crossref","first-page":"313","DOI":"10.1159\/000247386","article-title":"Multiple eruptive keratoacanthoma and immunity disorders","volume":"186","author":"Dangoisse","year":"1993","journal-title":"Dermatology"},{"key":"10.1016\/j.annder.2009.09.010_bib16","doi-asserted-by":"crossref","first-page":"173","DOI":"10.1016\/0190-9622(92)70021-7","article-title":"PUVA and skin cancer. A historical cohort study on 492\u00a0patients","volume":"26","author":"Chuang","year":"1992","journal-title":"J Am Acad Dermatol"},{"key":"10.1016\/j.annder.2009.09.010_bib17","first-page":"1286","article-title":"K\u00e9ratoacanthomes multiples sous cyclosporine","volume":"19","author":"Guillot","year":"1990","journal-title":"Presse Med"},{"key":"10.1016\/j.annder.2009.09.010_bib18","doi-asserted-by":"crossref","first-page":"S75","DOI":"10.1016\/j.jaad.2003.11.044","article-title":"Acute development of multiple keratoacanthomas and squamous cell carcinomas after treatment with infliximab","volume":"50","author":"Esser","year":"2004","journal-title":"J Am Acad Dermatol"},{"key":"10.1016\/j.annder.2009.09.010_bib19","doi-asserted-by":"crossref","first-page":"366","DOI":"10.2340\/00015555-0109","article-title":"Multiple keratoacanthomas as an untoward response to imiquimod therapy for actinic keratoses","volume":"86","author":"D\u2019Addario","year":"2006","journal-title":"Acta Derm Venereol"},{"key":"10.1016\/j.annder.2009.09.010_bib20","doi-asserted-by":"crossref","first-page":"96","DOI":"10.1001\/archderm.1996.03890250110027","article-title":"Keratoacanthomas and skin neoplasms associated with suramin therapy","volume":"132","author":"Kobayashi","year":"1996","journal-title":"Arch Dermatol"},{"key":"10.1016\/j.annder.2009.09.010_bib21","doi-asserted-by":"crossref","first-page":"886","DOI":"10.1001\/archderm.144.7.886","article-title":"Prospective study of the cutaneous adverse effects of sorafenib, a novel multikinase inhibitor","volume":"144","author":"Autier","year":"2008","journal-title":"Arch Dermatol"},{"key":"10.1016\/j.annder.2009.09.010_bib22","doi-asserted-by":"crossref","first-page":"448","DOI":"10.1111\/j.1525-1470.2006.00280.x","article-title":"Traumatic keratoacanthoma arising in a 15-year-old boy following a motor vehicle accident","volume":"23","author":"Janik","year":"2006","journal-title":"Pediatr Dermatol"},{"key":"10.1016\/j.annder.2009.09.010_bib23","doi-asserted-by":"crossref","first-page":"453","DOI":"10.1517\/14656566.7.4.453","article-title":"Sorafenib","volume":"7","author":"Rini","year":"2006","journal-title":"Expert Opin Pharmacother"},{"key":"10.1016\/j.annder.2009.09.010_bib24","doi-asserted-by":"crossref","first-page":"1226","DOI":"10.1038\/leu.2008.58","article-title":"Sorafenib inhibits activation of human peripheral blood T cells by targeting LCK phosphorylation","volume":"22","author":"Zhao","year":"2008","journal-title":"Leukemia"},{"key":"10.1016\/j.annder.2009.09.010_bib25","doi-asserted-by":"crossref","first-page":"820","DOI":"10.1001\/archderm.144.6.820","article-title":"Sorafenib-induced eruptive melanocytic lesions","volume":"144","author":"Kong","year":"2008","journal-title":"Arch Dermatol"},{"key":"10.1016\/j.annder.2009.09.010_bib26","doi-asserted-by":"crossref","first-page":"672","DOI":"10.1016\/j.annder.2008.04.016","article-title":"N\u00e6vus \u00e9ruptifs sous soraf\u00e9nib","volume":"135","author":"Bennani-Lahlou","year":"2008","journal-title":"Ann Dermatol Venereol"}],"container-title":["Annales de Dermatologie et de V\u00e9n\u00e9r\u00e9ologie"],"original-title":[],"language":"fr","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0151963809004281?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0151963809004281?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,27]],"date-time":"2025-09-27T10:55:49Z","timestamp":1758970549000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0151963809004281"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2009,12]]},"references-count":26,"journal-issue":{"issue":"12","published-print":{"date-parts":[[2009,12]]}},"alternative-id":["S0151963809004281"],"URL":"https:\/\/doi.org\/10.1016\/j.annder.2009.09.010","relation":{},"ISSN":["0151-9638"],"issn-type":[{"value":"0151-9638","type":"print"}],"subject":[],"published":{"date-parts":[[2009,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"K\u00e9ratoacanthomes multiples \u00e9ruptifs induits par le soraf\u00e9nib","name":"articletitle","label":"Article Title"},{"value":"Annales de Dermatologie et de V\u00e9n\u00e9r\u00e9ologie","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.annder.2009.09.010","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2009 Elsevier Masson SAS. All rights reserved.","name":"copyright","label":"Copyright"}]}}